Literature DB >> 15074712

The substrate activity of (S)-9-[3-hydroxy-(2-phosphonomethoxy)propyl]adenine diphosphate toward DNA polymerases alpha, delta and epsilon.

Gabriel Birkus1, Dominik Rejman, Miroslav Otmar, Ivan Votruba, Ivan Rosenberg, Antonin Holy.   

Abstract

In this study, we examined the substrate potency of (S)-9-[3-hydroxy-(2-phosphonomethoxy)propyl]- adenine diphosphate (HPMPApp) toward DNA polymerases alpha, delta and epsilon. The efficiency of HPMPApp incorporation decreased in the order pol epsilon >pol delta =pol alpha and was from 5.4- to 23-fold lower than that of dATP. Depending on which template-primer was used, the HPMPAppKm value was 3.3- and 8.3- (pol alpha), 3- and 0.82- (pol delta) or 2-fold (pol epsilon) higher than dATPKm. The ability of HPMPA to accumulate in DNA decreased in the order pol epsilon >pol alpha >pol delta. The difference between the elongation rate of DNA with and without one HPMPA molecule at 3' termini was about 1.1-2.3 fold. The 3'-5'-exonuclease activity of pol delta and epsilon can excise HPMPA from DNA. These observations indicate that interaction of HPMPApp with pol alpha, delta and epsilon may contribute to its cellular toxicity and explain its antiviral activity against polyomavirus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15074712     DOI: 10.1177/095632020401500103

Source DB:  PubMed          Journal:  Antivir Chem Chemother        ISSN: 0956-3202


  2 in total

1.  Solution structure of a DNA duplex containing the potent anti-poxvirus agent cidofovir.

Authors:  Olivier Julien; James R Beadle; Wendy C Magee; Subhrangsu Chatterjee; Karl Y Hostetler; David H Evans; Brian D Sykes
Journal:  J Am Chem Soc       Date:  2011-01-31       Impact factor: 15.419

2.  Cidofovir and (S)-9-[3-hydroxy-(2-phosphonomethoxy)propyl]adenine are highly effective inhibitors of vaccinia virus DNA polymerase when incorporated into the template strand.

Authors:  Wendy C Magee; Kathy A Aldern; Karl Y Hostetler; David H Evans
Journal:  Antimicrob Agents Chemother       Date:  2007-12-03       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.